Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for ...
As pharma shops for de-risked science, venture money is moving later and concentrating in fewer, bigger bets – our report ...
Nature Biotechnology paper offers a better way to judge models that predict gene effects. Shift plans to use it to hunt for ...
KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy ...
Cala Health’s kIQ Plus now offers three stimulation modes and a calibration before each use, and it’s available across the US ...
A day is a long time to study a donated human brain. Bexorg thinks it’s still too short. On 7 October, the Connecticut-based ...
Adjusting for how advanced patients’ disease was at the start lifts the Phase 2 result. The method was added after the trial ...
German biotech MODAG won for pairing a CE-marked diagnostic with a drug candidate that targets the same protein.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results